Margaret Duffy
MD
Margaret Duffy
CSO and Co-Founder
About
Margaret Duffy is the CSO and Co-Founder of Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies. She leads the company's scientific strategy from conception of the Adenovo™ platform and oncolytic candidate discovery to clinical development. Margaret co-founded Theolytics in 2017 as a spin-out from Oxford University.
Frequently asked
Who is Margaret Duffy?
Margaret Duffy is the CSO and Co-Founder of Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies. She leads the company's scientific strategy from conception of the Adenovo™ platform and oncolytic candidate discovery to clinical development. Margaret co-founded Theolytics in 2017 as a spin-out from Oxford University.
What is Margaret Duffy's current role?
Margaret Duffy is currently CSO and Co-Founder.
Comments
No comments yet. Be the first to share your take.
Profile
About Margaret Duffy
Margaret Duffy is CSO and Co-Founder. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.